Koyfin Home > Directory > Health Care > Aerie Pharmaceuticals > Return on Equity %

Aerie Pharmaceuticals Return on Equity % Chart (AERI)

Aerie Pharmaceuticals annual/quarterly Return on Equity % from 2013 to 2020.
  • Aerie Pharmaceuticals Return on Equity % for the quarter ending June 06, 2020 was -177.63 a 39.04% decrease of -69.34 year over year
  • Aerie Pharmaceuticals Return on Equity % for the last 12 months ending June 06, 2020 was -164.34 a 50.08% decrease of -82.30 year over year
  • Aerie Pharmaceuticals Annual Return on Equity % for 2019 was -101.12 a -26.58% increase of 26.88 from 2018
  • Aerie Pharmaceuticals Annual Return on Equity % for 2018 was -127.99 a 5.90% decrease of -7.55 from 2017
  • Aerie Pharmaceuticals Annual Return on Equity % for 2017 was -120.45 a -32.52% increase of 39.17 from 2016
Other Margins & Efficiency Metrics:
  • Aerie Pharmaceuticals Return on Capital % for the quarter ending September 09, 2018 was -52.21 a -6.48% increase of 3.38 year over year
View Chart On Koyfin

Quarterly AERI Return on Equity % Data

06/2020-177.63
03/2020-133.61
12/2019-117.11
09/2019-108.29
06/2019-108.45
03/2019-91.34
12/2018-82.93
09/2018-147.39
06/2018-102.10
03/2018-87.56

Annual AERI Return on Equity % Data

2019-101.12
2018-127.99
2017-120.45
2016-159.62
2015-317.68
2014-101.31
2013-93.80
2012-245.86